#1
The growing prevalence of respiratory tract diseases and immunodeficiency disorders, particularly among the geriatric population, is primarily driving the H1N1 vaccines market. Additionally, the launch of numerous favorable policies by government bodies and international organizations across counties to promote the development of competent variants and their effective distribution is further catalyzing the market growth.
loading